tradmap

DRTS Financials Alpha Tau Medical Ltd.

7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Financial health

  • Operating income covered interest expense -121.9× in the latest year.
  • The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
-$43M -$21M $0 2019 2020 2021 2022 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
0% 50% 100% 2019 2020 2021 2022 2023 2024 2025
GrossOperatingNet
Free cash flow (CFO − capex)
-$33M -$16M $0 2019 2020 2021 2022 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $12M $23M 2019 2020 2021 2022 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$90M $3M $97M $0 2019 2020 2021 2022 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 -$43M -$33M $12M
2024 -$32M -$22M $14M
2023 -$29M -$24M $13M
2022 -$34M -$25M $6M
2021 -$27M -$15M $23M
2020 -$9M -$11M $16M
2019 -$8M -$8M

Frequently asked questions

Is DRTS growing its revenue and profit?

See the revenue and net-income charts above for Alpha Tau Medical Ltd.'s multi-year trend.

How much debt does DRTS have?

As of FY2025, Alpha Tau Medical Ltd. reported — of total debt against $12M of cash; operating income covered interest expense -121.9×.

What is DRTS's profit margin?

In FY2025, gross margin was —, operating margin —, and net margin —.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.